2022 - Research.com Biology and Biochemistry in Denmark Leader Award
2015 - SPIE Fellow
2015 - OSA Fellows Peter E. Andersen Danmarks Tekniske Universitet, Denmark For contributions in light-tissue interactions specific to optical coherence tomography, including new laser diagnostic technology for biophotonic imaging.
Immunology, Tuberculosis, Mycobacterium tuberculosis, Virology and Antigen are his primary areas of study. Peter Andersen usually deals with Immunology and limits it to topics linked to Tuberculosis vaccines and Clinical trial. His research in Tuberculosis intersects with topics in T cell and Protein subunit.
His Mycobacterium tuberculosis research includes elements of Proteome, Disease and Microbiology. Peter Andersen studied Virology and Immunity that intersect with Booster dose and Dimethyldioctadecylammonium bromide. His biological study spans a wide range of topics, including Interferon gamma and Fusion protein.
The scientist’s investigation covers issues in Immunology, Optics, Tuberculosis, Antigen and Virology. His research ties Tuberculosis vaccines and Immunology together. His Tuberculosis study frequently draws connections to other fields, such as Interferon gamma.
His Antigen research is multidisciplinary, relying on both T cell, Molecular biology and Microbiology. He works mostly in the field of Virology, limiting it down to topics relating to Cytotoxic T cell and, in certain cases, CD8, as a part of the same area of interest. His Adjuvant research integrates issues from Liposome and Immunogenicity.
His primary scientific interests are in Immunology, Antigen, Tuberculosis, Adjuvant and Immune system. His biological study focuses on Cellular immunity. His work in the fields of Mycobacterium tuberculosis, Active tb and Tuberculin overlaps with other areas such as In patient.
His Adjuvant research focuses on Pharmacology and how it connects with CTL*. His work carried out in the field of Immune system brings together such families of science as Virology, Nasal administration, Cytokine and Drug delivery. The concepts of his Virology study are interwoven with issues in Epitope, Antibody, Chronic infection and In vivo.
His main research concerns Immunology, Tuberculosis, Adjuvant, Antigen and Mycobacterium tuberculosis. His work on Parenchyma expands to the thematically related Immunology. Peter Andersen is interested in Tuberculin, which is a branch of Tuberculosis.
His studies deal with areas such as Cytotoxic T cell, CD8, Immunogenicity and Virology as well as Adjuvant. His research in Antigen intersects with topics in QuantiFERON, Serology, Outpatient clinic and Confidence interval. His Vaccination research incorporates elements of Tuberculosis vaccines, Seroconversion, ESAT-6 and Immunization.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major.
Patricia A Darrah;Dipti T Patel;Paula M De Luca;Ross W B Lindsay.
Nature Medicine (2007)
Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis.
Ajit Lalvani;Roger Brookes;Robert J. Wilkinson;Adam S. Malin.
Proceedings of the National Academy of Sciences of the United States of America (1998)
Tuberculosis Subunit Vaccination Provides Long-Term Protective Immunity Characterized by Multifunctional CD4 Memory T Cells
Thomas Lindenstrøm;Else Marie Agger;Karen S. Korsholm;Patricia A. Darrah.
Journal of Immunology (2009)
Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6'-dibehenate) - A novel adjuvant inducing both strong CMI and antibody responses
Jesper Davidsen;Ida Rosenkrands;Dennis Christensen;Anil Vangala.
Biochimica et Biophysica Acta (2005)
Transient facial nerve paralysis (Bell's palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin.
David J. M. Lewis;Zhiming Huo;Susan Barnett;Ingrid Kromann.
PLOS ONE (2009)
Exchanging ESAT6 with TB10.4 in an Ag85B Fusion Molecule-Based Tuberculosis Subunit Vaccine: Efficient Protection and ESAT6-Based Sensitive Monitoring of Vaccine Efficacy
Jes Dietrich;Claus Aagaard;Robert Leah;Anja W. Olsen.
Journal of Immunology (2005)
Key epitopes on the ESAT-6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis.
L Brandt;T Oettinger;A Holm;A B Andersen.
Journal of Immunology (1996)
Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6.
Jan A.M. Langermans;T. Mark Doherty;Richard A.W. Vervenne;Tridia van der Laan.
Adjuvant modulation of immune responses to tuberculosis subunit vaccines.
E B Lindblad;M J Elhay;R Silva;R Appelberg.
Infection and Immunity (1997)
Prospective Evaluation of a Whole-Blood Test Using Mycobacterium tuberculosis-Specific Antigens ESAT-6 and CFP-10 for Diagnosis of Active Tuberculosis
Pernille Ravn;Martin E. Munk;Åse B. Andersen;Bettina Lundgren.
Clinical and Vaccine Immunology (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: